Q2 2019 Holdings
Filed 2019-08-14 | 19 holdings | $53.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gilead Sciences Inc(GILD)Call | COM | 375558103 | $10.1K | 150,000 | 19.0% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $5.9K | 20,000 | 11.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $4.8K | 120,000 | 9.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $4.7K | 70,000 | 8.9% |
| Abbvie Inc(ABBV)Call | COM | 00287Y109 | $3.6K | 50,000 | 6.8% |
| Johnson & Johnson(JNJ)Call | COM | 478160104 | $3.5K | 25,000 | 6.5% |
| Ligand Pharmaceuticals Inc(LGND)Put | COM NEW | 53220K504 | $2.9K | 25,000 | 5.4% |
| CVS Health Corp(CVS)Call | COM | 126650100 | $2.7K | 50,000 | 5.1% |
| Tyme Technologies Inc | COM | 90238J103 | $2.7K | 2,175,000 | 5.0% |
| Greenlane Hldgs Inc | CL A | 395330103 | $2.4K | 250,000 | 4.5% |
| Pfizer Inc(PFE) | COM | 717081103 | $2.2K | 50,000 | 4.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.1K | 250,000 | 3.9% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $1.4K | 1,800,000 | 2.6% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $1.2K | 200,000 | 2.3% |
| GW Pharmaceuticals PLCPut | ADS | 36197T103 | $1.0K | 6,000 | 1.9% |
| Cronos Group Inc(CRON)Put | COM | 22717L101 | $799 | 50,000 | 1.5% |
| Antares Pharma Inc(ATRSEUR)Call | COM | 036642106 | $658 | 200,000 | 1.2% |
| Proshares TR IICall | VIX SH TRM FUTRS | 74347W171 | $535 | 25,000 | 1.0% |
| Tyme Technologies IncCall | COM | 90238J103 | $122 | 100,000 | 0.2% |